Friday 10 November 2017

levulinic acid market projected to be 3,820 tons by 2020 : Grand View Research,Inc.

Global levulinic acid market demand was 2,606.2 tons in 2013 and is projected to be 3,820 tons by 2020. The increasing application of levulinic acid, especially in pesticides, solvents, pharmaceuticals, and cosmetics industries are anticipated to boost growth in the coming years.
Over the past few years, the chemical industry has continually been striving towards attaining a sustainable growth, with a focus on the development of renewable biotechnological and bio-based products. The production technology for bio-based levulinic acid has been simplified by dehydration of biomass or carbohydrates with acid. Levulinic acid is being increasingly used as a substitute to its synthetic counterparts in industrial usage.
The global levulinic acid market is anticipated to reach USD 19.65 million revenue, with a growing CAGR of 4.8% by 2020. Increasing usage of the acid in niche applications including plastics, nylons and rubbers are expected to drive demand in the coming years. Increasing R&D expenditure, mainly to diminish production costs of levulinic acid to competitive levels is a critical factor for market players.
Browse full report by Grand View Research: http://www.grandviewresearch.com/industry-analysis/levulinic-acid-market
Agriculture and pharmaceutical together accounted for over 66% of the overall volume in 2013. Demand for levulinic acid in the agricultural sector and its related applications is expected to grow at a CAGR of 6%, whereas the market is anticipated to grow at 5.4% CAGR from 2014 to 2020 in the pharmaceutical sector.
Apart from these applications, levulinic acid is also moderately used in the production of cigarettes to enhance delivery of nicotine in smoke, making it more receptive to neurons. Methyltetrahydrofuran (MTHF), a critical component of levulinic acid acts as a fuel additive. MTHF is commercially used in automotive segments as fuel extenders and is projected to have a potential demand of 20,000 kilo tons by 2020.
North America dominated the levulinic acid market contributing to more than 41% of the overall demand in 2013. Levulinic acid demand in the region is anticipated to be 1,598.3 tons by 2020, growing at a CAGR of 5.6% over the forecast period, owing to the presence of the prominent application players in the region.
Europe and Asia Pacific are emerging markets for levulinic acid. China, being one the major suppliers, manufactures, and sells the product at a relatively lower price to companies present in the U.S. and Europe which produce downstream products of the chemical. Europe, being the second largest consumer, accounted for 31% of the overall market volume in 2013.
Major market players include Segetis, Biofine, and DuPont. China has large an unorganized manufacturing base with major suppliers being Ouyi Pharmaceutical Co Ltd. and Shijiazhuang Pharmaceutical Group. Biofine has been one of the prominent manufacturers in the industry, with a key focus on MTHF and DALA applications.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/renewable-chemicals
Grand View Research has segmented the global levulinic acid market on the basis of application and region:
Levulinic Acid Application Outlook
        • Pharmaceuticals
        • Agriculture (Organic potassium fertililizer DALA, 2--Methylindole-3-acetic acid)
        • Food Additives
        • Cosmetics
Levulinic Acid Regional Outlook
        • North America
        • Europe
        • Asia Pacific
        • Rest of the World
Bio-based Levulinic Acid Potential Downstream Platform Outlook
        • Methyltetrahydrofuran (MTHF)
        • Delta aminolevulinic acid (DALA)
        • Diphenolic Acid
        • Others
Access press release by Grand View Research: http://www.grandviewresearch.com/press-release/global-levulinic-acid-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com
at No comments:

Pain management devices market is expected to reach USD 8.6 billion by 2022 : Grand View Research,Inc.

Global pain management devices market is expected to reach USD 8.6 billion by 2022, according to a new study by Grand View Research, Inc. The rising prevalence of diabetes coupled with an increase in the geriatric population base worldwide is the major factor attributing towards the significant growth of the market. Furthermore, the growing preference for these devices over oral drugs and surgical interventions is a high impact rendering driver for the market’s growth over the coming seven years.
The pain management devices industry is also expected to show exuberant growth as a consequence of the technological advancements happening in this field. The advancements include the advent of products such as electrode-based wearable automatic transcutaneous electrical nerve stimulator devices, which provide peripheral pain management in a 60-minute run cycle. 
Further key findings from the study suggest:
  • The neurostimulation devices market had a revenue share of over 48.9% in 2014. The major factors attributing towards the dominance of this segment can be attributed to the extensive usage of neurostimulation devices in chronic pain management. These devices are preferred over the available traditional technologies owing to their higher efficiency in terms of providing relief for a longer duration.
  • Radiofrequency ablation device market is expected to grow at a lucrative CAGR of over 14% in the coming years. Rising usage of these devices to cure cancer patients is the major factor contributing towards their high growth. Furthermore, the long-term relief provided from the cancer pain through the use of these devices is also a high impact rendering driver for this segment
  • These devices are also analyzed on the basis of their applications in cancer pain, neuropathy pain, facial pain & migraine, musculoskeletal diseases, and trauma pain
  • Regionally, the North American pain management devices held around half of the global revenue share owing to the rising number of people affiliated with pain requiring management devices. Sophisticated healthcare infrastructure, rising adoption of pain management equipment by healthcare professionals and patients over conventional treatment therapies are further anticipated to accentuate the industry’s growth in this region
  • Asia Pacific region is expected to grow at a lucrative rate during the forecast period, due to increasing demand for these devices as a consequence of rising need to curb cancer and diabetes related chronic pain in a cost effective manner. Furthermore, the rapidly improving healthcare infrastructure in countries such as India and Japan also contributed towards market growth in this region
  • The key players operating in the pain management devices industry include B Braun Melsungen AG., Baxter International, Inc., Boston Scientific Corporation, Codman and Shurtleff, DJO Global LLC, Pfizer, Medtronic Plc, Smiths Medical, St. Jude Medical, and Stryker Corporation. These companies are involved in launching novel devices to fill in the vacuum created by the deteriorating demand for oral drugs for pain management. 
Grand View Research has segmented the pain management devices market on the basis of products and region:
Global Pain Management Devices Market By Type Outlook
  • Electrical stimulators
    • TENS
    • Others
  • Radiofrequency ablation
  • Analgesic infusion pumps
    • Intrathecal infusion pumps
    • External infusion pumps
  • Neurostimulation
    • Spinal cord stimulators
    • Deep brain stimulators
    • Sacral neurostimulators
Global Pain Management Devices Market By Application
  • Electrical stimulators
    • Cancer
    • Neuropathic pain
    • Facial &migraine
    • Musculoskeletal disorders
    • Trauma
  • Radiofrequency ablation
    • Cancer
    • Neuropathic Pain
    • Musculoskeletal disorders
  • Analgesic infusion pumps
    • Cancer
    • Neuropathic pain
    • Musculoskeletal disorders
    • Trauma
  • Neurostimulation
    • Cancer
    • Neuropathic pain
    • Facial &migraine
    • Musculoskeletal disorders
Global Pain Management Devices Market By Region
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
Access press release by Grand View Research : http://www.grandviewresearch.com/press-release/global-rubber-processing-chemicals-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com
at No comments:

Medical Nonwoven Disposables Market Projected to reach USD 10.05 billion by 2020 : Grand View Research,Inc.

Global Medical Nonwoven Disposables Market is expected to reach USD 10.05 billion by 2020, according to a new study by Grand View Research, Inc. Increasing prevalence of hospital acquired infections and other infections such as hepatitis and AIDS, and the introduction of favorable initiatives and reforms promoting the use of nonwoven in government hospitals are some factors expected to drive the medical nonwoven disposables market growth during the forecast period. Rapidly growing geriatric population base is another high impact rendering driver for the medical nonwoven disposables market as aging is considered as one of the greatest risk factor for the development of incontinence. Furthermore, people of this age group are more likely to accept their symptoms and use incontinence products.
The hygiene products segment in the medical nonwoven disposables market is expected to grow at a lucrative rate of over 7.0% during the forecast period. The lucrative growth of this segment can be attributed to the growing prevalence of incontinence and the presence of high unmet medical needs pertaining to this segment. Constantly improving patient awareness levels and the introduction of new and efficient products is expected to drive segment growth during the forecast period. Hygiene disposables are also expected to witness a growth in usage rates over the next six years, owing to the introduction of cost effective products such as cheap non woven ostomy liners.
Further key findings from the study suggest:
  • Disposable diapers are expected to grow at a lucrative rate during the forecast period. Rising patient awareness levels pertaining to incontinence and the advantages offered by related products are some key factors attributing to the growth of this segment.
  • North America was the most mature regional market in 2013, accounting for over 35.0% of revenue. High prevalence of incontinence is the most significant growth driver of this market. Furthermore, presence of sophisticated healthcare infrastructure, high patient awareness levels are some factors attributing to the high demand for medical nonwoven disposables in the region.
  • Asia Pacific is identified as the most lucrative medical nonwoven disposables regional market. Rapid improvement in healthcare infrastructure and the presence of high unmet needs in the emerging markets of China and India are some factors expected to present manufacturers with lucrative future growth opportunities.
  • Some key players of manufacturing medical nonwoven disposables include Svenska Cellulosa Aktiebolaget (SCA), Kimberly-Clark, and Covidien.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global medical nonwoven disposables market on the basis of product and region:
Global Medical Nonwoven Disposables Product Outlook (Market Revenue in USD Million, 2012 - 2020)
  • Hygiene products
    • Disposable Incontinence Pads & Ostomy Liners
    • Disposable Panty Shields
    • Disposable Underwear
    • Disposable Diapers
      • Ultra-Absorbent Disposable Diapers
      • Super-Absorbent Disposable Diapers
      • Gender-Specific Disposable Diapers
      • Biodegradable Disposable Diapers
      • Regular Disposable Diapers
    • Nonwoven Medical Supplies
      • Disposable Surgical Masks
      • Disposable Surgical Drapes
      • Disposable Surgical Caps
      • Disposable Surgical Gowns
      • Disposable Sterile Nonwoven Swabs
Medical Nonwoven Disposables Regional Outlook (Revenue, USD Million, 2012 - 2020)
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • RoW
Access press release by Grand View Research :   http://www.grandviewresearch.com/press-release/global-medical-nonwoven-disposables-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com
at No comments:

3D Cell Culture Market Anticipated to reach USD 1.69 billion by 2024 : Grand View Research, Inc.

The global 3D cell culture market is anticipated to reach USD 1.69 billion by 2024, according to a new report by Grand View Research, Inc. Potential of this technology to replace and reduce the usage of animal models for histological analysis and biochemical assays is expected to fuel demand for 3D cell culture products thus driving growth in the coming years.
Advent of technology with respect to spheroid formation and matured assay methods, is expected to boost the emergence of 3D optimized assays, kits, and protocols, in turn, expediting the entire research process. In addition, the scope of three-dimensional (3D) cell culturing experiments for evaluation of drug moiety is anticipated to grow owing to advantages associated with its usage. These advantages include increased cell to extra cellular matrix (ECM) as well as intercellular interactions, variation in the proliferation zones, ease for analyzing impact of site-specific stromal tissue components in the tumor microenvironment.
Research initiatives carried out to develop multidimensional cultures that offer compatibility with automated lab equipment and suitability for HTS feature in order to facilitate high content screening assay, signaling, and migration are expected to fuel the growth of this vertical through to 2024.
Further key findings from the report suggest:
  • Scaffold-based technique accounted for the revenue share of over 40% because of the potential these possess for the recreation of structural and physical environment of a living tissue. Availability of choice for the material and structure of the scaffold for different in vitro applications is supportive for the estimated revenue share of this segment. Hydrogel or ECM and solid scaffolds are estimated to capture a comparatively sizable share of the revenue, attributed to the presence of different products in this segment.
  • Spheroid development techniques are estimated to contribute significantly in increasing the revenue share of scaffold-free technology. These enable multicellular arrangement, thus making them an influential tool for a range of applications, particularly in cancer and stem cell research.Oncology is estimated to account for the dominant share in 2015 owing to the presence of higher incidence rate of cancers coupled with phenotypic heterogeneity achieved using 3D culturing. Stem cell research is anticipated to witness lucrative growth in the coming years as a consequence of the upcoming projects in this segment for development of effective therapies.
  • Key end users for this technology are pharma & biotech entities, research laboratories and institutes. Pharma & biotech entities accounted for the largest share of the revenue in 2015 owing to the high usage of technology in different steps of drug discovery which include target validation, lead optimization, penetration studies, and safety assessment or toxicity screening.
  • North America dominated the next generation sequencing data analysis market with a share of over 40% as a result of the presence of several organizations operating in this region. Moreover, the significant number of R&D projects carried out in institutes is resulting in the high demand, affecting the revenue growth significantly.
  • However, Asia Pacific is expected to witness substantially high growth through to 2024, which is attributable to the rise in number of research grants for drug development and tissue engineering projects in the developing economies of this region. Furthermore, positive R&D outcomes encouraging the incorporation of three dimensional cultures in regenerative medicine is expected to impact this sector with potential opportunities for growth.
  • The market is fragmented in nature and includes established as well as emerging players These entities include 3D Biomatrix, Corning Inc, Nano3D Biosciences, Merck, Becton Dickinson and Company, Thermo Fisher Scientific, InSphero AG, Lonza Group, Tecan, 3D Biotek LLC, VWR International, LLC, and Global Cell Solutions, Inc.
  • These companies are involved in collaborations and co-marketing agreements for enhancement of product portfolio as well as global presence. For instance, Tecan and CellSpring entered into collaboration for automation of the 3D Bloom platform on a Freedom EVO workstation.
Browse more reports of this category by Grand View Research:
http://www.grandviewresearch.com/industry/biotechnologyhttp://www.grandviewresearch.com/industry/biotechnology
 Grand View Research has segmented 3D cell culture market on the basis of technology, application, end use and region:
Global 3D Cell Culture Outlook, by Technology (Revenue, USD Million, 2013 - 2024)
  • Scaffold Based
    • Hydrogels
    • Polymeric Scaffolds
    • Micro - patterned Surface Microplates
  • Scaffold Free
    • Hanging Drop Microplates
    • Spheroid Microplates with ULA coating
    • Microfluidic 3D Cell Culture
    • Magnetic Levitations & 3D Bioprinting
  • Bioreactors
Global 3D Cell CultureOutlook, by Application (Revenue, USD Million, 2013 - 2024)
  • Cancer
  • Tissue Engineering & Immunohistochemistry
  • Drug Development
  • Stem Cell Research
  • Others
Global 3D Cell CultureOutlook, by End - use, (Revenue, USD Million, 2013 - 2024)
  • Biotechnology and Pharmaceutical Industries
  • Research Laboratories and Institutes
  • Hospitals and Diagnostic Centers
  • Others
Global 3D Cell Culture Market, Regional Outlook (Revenue, USD Million, 2013 - 2024)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Brazil
  • MEA
    • South Africa
Access press release by Grand View Research : http://www.grandviewresearch.com/press-release/global-3d-cell-culture-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com
at No comments:

Rubber Processing Chemicals market Expected to reach USD 6.11 billion by 2024 : Grand View Research,Inc.

The global rubber processing chemicals market is expected to reach USD 6.11 billion by 2024, according to a new report by Grand View Research, Inc. Increasing demand for rubber products, both tire, and non-tire, exhibiting excellent durability, and superior performance under extreme weather conditions, is expected to augment rubber processing chemicals demand.
Growing demand for automobiles and aftermarket is expected to subsequently drive demand for tires over the forecast period. The growth of the market depends majorly on tire industry which includes both, natural and synthetic rubber. Factors such as green tires & high-performance tires, improved fuel efficient tires in emerging countries are driving the demand for rubber processing chemicals.
Browse full report by Grand View Research :
http://www.grandviewresearch.com/industry-analysis/rubber-processing-chemicals-market
Further key findings from the study suggest:
  • Global rubber processing chemicals market was worth USD 4,201.5 million in 2015 and is foreseen to be valued at USD 6,105.8 million by 2024, growing at a CAGR of 4.3% from 2016 to 2024
  • Asia Pacific accounted for 47.2% of the volume share, thus, dominating the global market in 2015 owing to high demand for the chemical from the developing automotive industry in emerging economies such as China, and India
  • China was the largest producer as well as consumer of the rubber processing chemicals owing its rising population and presence of huge secondary processed products manufacturing sector in the country. The Chinese rubber processing chemicals market is projected to reach USD 1.93 billion by 2024.
  • Flame retardants accounted for 5.6% of the volume share in 2015. However, the segment is expected to witness fastest growth over the forecast period on accounting of rising awareness regarding safety and protection. Fire safety regulations implemented by several governments across the globe is likely to result in growing demand for flame retardant rubber products.
  • Non-tire rubber accounted for 43.5% of the volume share in 2015. Non-tire rubber is majorly used in industrial belts. Rapid industrialization with high growth in the manufacturing sector is expected to propel the market growth for non-tire rubber application.
  • Latin America rubber processing chemicals market was estimated at 185.6 kilo tons in 2015. Automotive companies are focusing on demographic trends such as targeting-middle class population and producing low-cost cars. Increasing car consumption in this region is expected to fuel the growth for rubber tires, which is the major application for rubber chemicals.
  • Lanxess AG, Solvay SA, AkzoNobel N.V., BASF SE, Arkema SA, Eastman Chemical Company and Kumho Petrochemicals are some of the key market players. The market is characterized by the integration of numerous key players across the value chain at stages involving raw material supply and rubber processing chemicals manufacturing. Moreover, these companies are focusing on increasing their penetration within the industry through production expansion and tie-ups with distributors.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/plastics-polymers-and-resins
Grand View Research has segmented the global rubber processing chemicals market on the basis of product, application and region:
Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2013 - 2024)
  • Anti-degradants
  • Accelerators
  • Flame Retardants
  • Processing Aid/ PromotersOthers
    • Release Agents
    • Curing & Blowing Agents
    • Others
  • Others
Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2013 - 2024)
  • Tire
  • Non-Tire
Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2013 - 2024)
  • North America
    • U.S.
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
  • Latin America
    • Brazil
  • MEA
Access press release by Grand View Research : http://www.grandviewresearch.com/press-release/global-rubber-processing-chemicals-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com
at No comments:

Insomnia Therapeutics Market expected to reach USD 3.45 billion by 2025 : Grand View Research,Inc.

The global insomnia therapeutics market is expected to reach USD 3.45billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by thepresence of patented molecules, potential clinical pipeline candidates, rising stress level,and increase in geriatric population who find it difficult to fall asleep. Increase in prevalence of insomnia &awareness about this conditionand availability of safer drugs are anticipated to fuel revenue growth.
Insomnia is estimated to affect approximately 35% of the global population. Differentpatternsof the condition include difficulty in sleep initiation and maintenance, which is generally accompanied with frequent awakenings&awakening too early with trouble sleepingagain. Long-terminsomnia can hamper everyday life, which may result in nonproductive work hours. If left untreated, this conditionmay lead to severe depression and nervous breakdown of the patient.
Factors influencing insomnia therapeutics market growth includerising stress level, presence of patented molecules in the market, potentialdrugs in clinical pipeline, introduction of technologically advanced medical devices, and growinggeriatric population.Growing awareness about the impact of sleep deprivation on everyday lifeis anticipated to increaseadoption rate of various treatments for insomnia, which is expected to lead to revenue growth of the insomnia therapeutics market.
Currently, widely adopted treatment options for insomnia include generic nonbenzodiazepines and antidepressants even though other novel agents such as orexin antagonists and melatonin antagonists are available in the market.Launch of Eisai’s Lemborexant is expected to cater to unmet medical needs in this segment and fuel growth of this market over the forecast period. According toUnited Nations (UN) report in 2015, population in the age group of 60 years and above is projected to grow by 56% and is expected to reach around 1.4 billion by 2030. These statistics indicate the growing geriatric population. Since this population base is more susceptible to sleep deprivation, the demand for insomnia therapeutics is anticipated to increase.
Further Key Findings From the Report Suggest:
  • North America held majority of the share in 2016 due to increase inawareness about diseases, growing geriatricpopulation, and high adoption of therapeutics for treatment.
  • The U.S. dominated North America owing to the presence of largest sleep-deprived population and use of patented drugs for treatment.
  • Japan is the second largest market after the U.S. Asia Pacific is expected to be the fastest growingmarket due to the presence ofemerging economies like China & India and launch of new drugs.
  • Some of the key players are Takeda Pharmaceutical Co. Ltd.; Vanda Pharmaceuticals; Merck & Co, Inc.;Pfizer Inc.; Teva Pharmaceutical Industries Ltd.; Mylan N. V.; Sumitomo Dainippon Pharma Co., Ltd.; Sanofi; Paratek Pharmaceuticals;and Ebb Therapeutics.
Browse more reports of this category by Grand View Research :  http://www.grandviewresearch.com/industry/healthcare
Grand View Research has segmented the insomnia therapeutics market on the basis of treatment type, sales channel, and region:
Insomnia Therapeutics Market Treatment Type Outlook (Revenue, USD Million, 2014 – 2025)
  • Drugs
    • Benzodiazepines
    • Nonbenzodiazepines
    • Antidepressants
    • Orexin antagonist
    • Melatonin antagonist
    • Others
  • Devices
Insomnia Therapeutics Market Sales Channel Outlook (Revenue, USD Million, 2014 – 2025)
  • Prescription
  • Over-the-Counter(OTC)
Insomnia Therapeutics Market Regional Outlook (Revenue, USD Million, 2014 – 2025)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com
at No comments:
Subscribe to: Posts (Atom)